Eris Lifesciences witnessed a substantial block deal on August 22, with approximately 98.9 lakh shares, representing 7.27% of its equity, changing hands for ₹1,201 per share, totaling ₹1,187 crore.
Details about the buyers and sellers involved in this transaction are currently unavailable.
The stock was trading at Rs 1,247.45 per share on the National Stock Exchange (NSE), showing a nearly 3% increase. Over the past three days, the stock has appreciated by 3.75%. On Thursday morning, it opened with a 2.50% gain at ₹1,243.15 and reached an intraday high of Rs 1250 per share, up by 3.07%.
TOPICS:
Eris Lifesciences